(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NYPOZI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

NYPOZI

ST13

US500000097388041

Class

5

Filing

97388041

Registration

8152232

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

02/25/2026

Classification

Registered

Trademark type

Word

Nice classes

5

Filing date

04/29/2022

Registration date

02/24/2026

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/24/2026

Last transaction

02/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

09/23/2025

First use in commerce

09/23/2025

Drawing code

4

Owner type

03

Owner location

Grand Cayman, KY

Examiner

STERLIN, DEBORAH L

Law office

N80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Tanvex BioPharma, Inc.

Representatives

GABRIELLE S. ROTH SUGHRUE MION, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditionsincluding those caused by cancer treatments

Publications

History of USPTO decisions and trademark events.

31 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/24/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

02/05/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

02/05/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/05/2026

IUAF

USE AMENDMENT FILED

11/19/2025

EISU

TEAS STATEMENT OF USE RECEIVED

11/19/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

05/06/2025

EX4G

SOU EXTENSION 4 GRANTED

05/05/2025

EXT4

SOU EXTENSION 4 FILED

05/05/2025

EEXT

SOU TEAS EXTENSION RECEIVED

05/05/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

10/31/2024

EX3G

SOU EXTENSION 3 GRANTED

10/31/2024

EXT3

SOU EXTENSION 3 FILED

10/31/2024

EEXT

SOU TEAS EXTENSION RECEIVED

10/31/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/27/2024

EX2G

SOU EXTENSION 2 GRANTED

04/26/2024

EXT2

SOU EXTENSION 2 FILED

04/26/2024

EEXT

SOU TEAS EXTENSION RECEIVED

04/26/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/04/2023

EX1G

SOU EXTENSION 1 GRANTED

11/02/2023

EXT1

SOU EXTENSION 1 FILED

11/02/2023

EEXT

SOU TEAS EXTENSION RECEIVED

11/02/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/23/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/28/2023

PUBO

PUBLISHED FOR OPPOSITION

03/28/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/08/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/22/2023

DOCK

ASSIGNED TO EXAMINER

02/17/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/04/2022

NWAP

NEW APPLICATION ENTERED

05/03/2022

Continuous trademark protection

Get notified about every new filing that threatens NYPOZI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.